R. Lor Randall, MD, FACS

R. Lor Randall, MD, FACS, is the David Linn Endowed Chair for Orthopedic Surgery and chair of the Department of Orthopedic Surgery as well as a professor at the University of California Davis.

Articles

Dr Randall on Evaluating Osteosarcoma Progression in a Bioengineered Bone Marrow Matrix

March 14th 2025

R. Lor Randall, MD, FACS, discusses the application of a bioengineered bone marrow matrix as a three-dimensional model to analyze osteosarcoma cell behavior under varying oxygen tensions.

Dr Randall on the Utility of Intraoperative Peripheral Margin Assessment in Soft Tissue Sarcomas

February 24th 2025

R. Lor Randall, MD, FACS, discusses the utility of routine intraoperative frozen margin assessment in soft tissue sarcoma.

Dr Randall on the Effect of Socioeconomic Factors in Pediatric Nonmetastatic Osteosarcoma

November 5th 2024

R. Lor Randall, MD, FACS, discusses the impact of race, ethnicity, and socioeconomic factors on outcomes in pediatric patients with nonmetastatic osteosarcoma.

Dr Randall on the Role of EZH2 in Doxorubicin Resistance in Soft Tissue Sarcoma

August 15th 2024

R. Lor Randall, MD, FACS, discusses the role of EZH2 in doxorubicin resistance in soft tissue sarcoma.

Dr Randall on One-stage Synovectomy in D-TGCT

June 14th 2023

R. Lor Randall, MD, FACS, discusses findings from a study of one-stage synovectomy in patients with diffuse-type tenosynovial giant cell tumor of the knee.

Dr Randall on the Evaluation of Ganitumab Plus VDC/IE in Newly Diagnosed Metastatic Ewing Sarcoma

April 13th 2023

R. Lor Randall, MD, FACS, discusses the investigation of ganitumab plus standard-of-care interval-compressed chemotherapy in a phase 3 trial for newly diagnosed metastatic Ewing sarcoma.

Dr Randall on the Presentation and Symptoms of Mesenchymal Chondrosarcoma

March 24th 2023

R. Lor Randall, MD, FACS, discusses the potential symptoms and presentation of mesenchymal chondrosarcoma, as well as highlighted recent case studies that he consulted on for patients with mesenchymal chondrosarcoma.

Dr. Randall on the Diagnosis of Mesenchymal Chondrosarcoma

March 20th 2023

R. Lor Randall, MD, FACS, discusses, the importance of correctly diagnosing mesenchymal chondrosarcoma.

Dr. Randall on Preventing Early Failures With Osseointegrated Endoprostheses in Bone Sarcomas

January 6th 2022

R. Lor Randall, MD, FACS, discusses methods of preventing early failures with compressive osseointegrative endoprosthetic devices of the femur in bone sarcomas.

Dr. Randall on the Evolution of Limb Salvage Technologies in Bone Sarcomas

December 10th 2021

R. Lor Randall, MD, FACS, discusses the evolution of limb salvage technologies in bone sarcomas.

Dr. Randall on Initial Considerations When Treating Patients With Desmoid Tumors

October 26th 2021

R. Lor Randall, MD, FACS, discusses initial considerations when treating patients with desmoid tumors.

Dr. Randall on the Evolution of Orthopedic Surgery in Sarcoma

November 16th 2020

R. Lor Randall, MD, FACS, discusses the evolution of orthopedic surgery in sarcoma.

Dr. Randall on the SAFETY Trial in Soft Tissue Sarcoma

February 14th 2020

R. Lor Randall, MD, FACS, discusses the SAFETY trial (NCT03944798) in soft tissue sarcoma.

Dr. Randall of Tumor Sequencing Research in Sarcomas

January 30th 2020

R. Lor Randall, MD, FACS, discusses ongoing research in sequencing the tumors of patients with primary bone or tissue sarcomas.

Dr. Randall on Using Pexidartinib to Treat Tenosynovial Giant Cell Tumor

October 9th 2019

R. Lor Randall, MD, FACS, discusses using pexidartinib to treat tenosynovial giant cell tumor.